U.S. Sen. Charles Grassley says health plans ‘continue to defraud’ taxpayers in letter asking questions of Eden Prairie-based health care giant.

The Wall Street Journal continues to report misinformation on the Medicare Advantage (MA) program. The government regularly reviews all MA plans to ensure compliance and we consistently perform at the industry's highest levels on those reviews.

The Wall Street Journal says the U.S. Justice Department in recent months has launched an investigation into UnitedHealth Group’s billing practices to see if the company fraudulently used diagnosis data to trigger extra Medicare Advantage payments.

Sen. Chuck Grassley (R-Iowa) has given UnitedHealth Group two weeks to explain its method for documenting Medicare Advantage enrollees' diagnoses.

UnitedHealth Group shares tumbled Friday on a report that the U.S. Department of Justice has started an investigation into the health care giant’s Medicare billing practices. The Wall Street Journal said federal officials have launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage,

Key Takeaways Shares of UnitedHealth Group sank Friday following a report that the U.S. Department of Justice is investigating the company's diagnosing practices.The Wall Street Journal reported that the DOJ is probing whether the company tends to over-diagnose conditions that can earn larger Medicare Advantage payouts.

Senator Chuck Grassley has launched an inquiry into UnitedHealth Group's Medicare Advantage billing practices following a report from The Wall Street Journal stating the company is being investigated by the U.

The U.S. Department of Justice is investigating billing practices at UnitedHealth Group following reports that the company inflated charges to maximize Medicare Advantage reimbursements, The Wall Street Journal reported in an exclusive.

The Department of Justice is probing UnitedHealth Group's billing practices  in Medicare Advantage, according to a report from the Wall Street Journal. | The Department of Justice is probing UnitedHealth Group's billing practices in Medicare Advantage,

Amid the U.S. Department of Justice’s (DOJ) legal battle with UnitedHealth Group (NYSE: UHG) regarding the planned purchase of Amedisys (Nasdaq: AMED),

UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare Advantage billing practices, and the second was a Congressman's investigation into a decline in care quality at Optum-owned clinics in New York.

The US Justice Department has been investigating UnitedHealth Group Inc.’s Medicare billing practices, a person familiar with the matter said. The company’s stock fell sharply. The Wall Street Journal first reported the civil fraud investigation into whether the insurance giant’s practices related to patient diagnoses force higher payments from the government’s Medicare Advantage program.